Emerson Electric Co (EMR)
Industrials · Electrical Components & Equipment · US stock · S&P 500 component
$160.29
▼ -2.82 (1.73%)
Fair valueFair
$146 −8.9% to fair value
$73fair band $124–$177$219
Day's range
$154.52 – $162.04
52-week range
$122.64 – $166.35
About Emerson Electric Co
Emerson is an industrial technology company that supplies automation systems, software and equipment used to control and measure processes in factories and plants. Its products include control systems, valves, flow and pressure measurement devices, test and measurement equipment and industrial software. Customers include chemical, oil and gas, power, life sciences and discrete manufacturing companies. It has reshaped its portfolio through acquisitions and disposals, and now concentrates on automation.
Revenue comes from automation hardware, software and services. Sales were $18.6 billion over the last twelve months, and growth over the last three years is 121.4% a year, a figure to read with care given changes to the group. The operating margin is 17.6%, and the business earns a profit of 8% on the capital invested in it. Net debt is 2.3 times EBITDA. It pays a dividend with a yield of 1.4%. On the site's X-Ray Score it receives 49 out of 100.
Price chart
52-wk range $122.64 – $166.35Volume 3,974,389Daily, split-adjusted
Vitals
Market cap$89.9B
52-week range$122.64 – $166.35
Volume (last day)3,974,389
P/E (TTM)35.1
EBIT / EV yield3.3%
Free-cash-flow yield3.8%
Dividend yield1.4%
Revenue (TTM)$18.6B
Net income (TTM)$2.6B
Operating margin17.6%
Return on capital8.2%
Debt incl. leases$13.1B
Cash & securities$2.2B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies that hold large long-term investments). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$146middle half of models $105 – $181
Fair
−8.9% to fair value
Average of the 15 valuation models that pass our checks: multiples, discounted cash flow, dividend discount and earnings power value. A model more than 100% above or 60% below the price is left out as unrealistic. Model uncertainty is High, based on how far apart the models are. Undervalued or Overvalued means the gap to fair value is more than 17.5%.
Price $160
Undervalued < $124Fair $124 – $177Overvalued > $177
P/E multiple
$152
P/B multiple
$162
P/S multiple
$157
EV/EBITDA multiple
$163
EV/EBIT multiple
$156
EV/revenue multiple
$154
10-year DCF, EBITDA exit
$200
5-year DCF, EBITDA exit
$203
10-year DCF, revenue exit
$198
5-year DCF, revenue exit
$200
10-year DCF, growth exit
$93
5-year DCF, growth exit
$76
Dividend discount, stable
$99
Dividend discount, multi-stage
$111
Earnings power value
$67
Growth the price implies
26.6%/yr
A model estimate, not a price target or recommendation. Inputs: risk-free 5.13%, equity risk premium 4.30% (Damodaran). How it works.
What this means
Weak business, fairly priced
The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Industrials peers. Open a lens to see the numbers behind it.
Strong: 70 to 100Fair: 50 to 69Weak: under 50No score: not enough data
Valuation
Weak
41/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield3.3%
Free-cash-flow yield3.8%
Fair value vs price0.9×
Growth
Strong
73/100
Growing faster than most of its sector.
See the numbers →
Revenue growth (3y)121.4%
Growth consistency100%
Profitability
Weak
35/100
Earns lower returns on its capital than most peers.
See the numbers →
Return on invested capital8.2%
Operating margin17.6%
Gross profitability23.5%
Financial health
Fair
58/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score7 / 9
Net debt / EBITDA2.3×
Interest coverNo interest cost
Dividends
Weak
39/100
Dividend is modest or less certain than peers.
See the numbers →
Dividend yield1.4%
Dividends vs free cash flow36%
Quarterly results: last 6 quarters
+1.3%
Mar '25
+3.9%
Jun '25
+5.1%
Sep '25
+4.1%
Dec '25
+2.9%
Mar '26
+7.0%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $4.9B, diluted EPS $1.28.
Compare with peers
VRT Vertiv Holdings Co58 AME Ametek Inc/48 ROK Rockwell Automation, I...47 ETN Eaton Corp plc41Other Electrical Components & Equipment companies by X-Ray Score.
SWOT analysis: Emerson Electric Co
Strengthsinside the company
- Revenue has grown 121.4% a year over three years (median 9.8% for industry peers).
- Operating profit covers interest 50x, so debt costs are a small drag.
- Passes 7 of the 9 Piotroski tests, which points to improving profitability, funding and efficiency.
Weaknessesinside the company
- No clear weakness in the figures we track.
Opportunitiesvaluation and setting
- Dividends use only 36% of free cash flow, which leaves room to raise them.
- Price momentum is strong on the weekly and monthly signals (trends can reverse).
Threatsvaluation and setting
- Revenue growth slowed to 3.0% last year from 121.4% a year over three years.
- Valuation uncertainty is high: the models give widely different values, so the fair value range is wide.
Written by fixed rules from the figures on this page and the peer table below: filings, our fair value, the sector climate and the price trend. It summarises the data, it is not a forecast or advice.
Compare EMR with peers and sector
Medians of 5 Electrical Components & Equipment peers and of 80 Industrials stocks in our universe.
Largest peers (X-Ray Score): ETN 41, VRT 58, BE 32, AME 48, ROK 47.
| Metric | EMR | Peers | Sector |
|---|---|---|---|
| X-Ray Score (out of 100) | 49 | 47 | 51 |
| Valuation | 40 | 26 | 48 |
| Growth | 73 | 76 | 50 |
| Profitability | 35 | 49 | 51 |
| Financial health | 58 | 49 | 49 |
| Dividends | 39 | 53 | 53 |
Sector leaders: highest X-Ray Score in Industrials
EMR ranks #47 of 81 in Industrials and #2 of 6 in Electrical Components & Equipment by X-Ray Score. A higher score is stronger on our five pillars; it is a ranking of facts, not a forecast.
Green means better than the peer median, red worse (only where a higher or lower figure is clearly better). A dash means too few companies report the figure. P/E, EV/EBITDA and price changes are not graded: a different level is not good or bad by itself.
Factor ratings for EMR
Each factor is rated by where EMR stands among the 81 Industrials stocks in our universe.
Rating against the sector
Goodthe top third of these stocks
Averagethe middle third of these stocks
Badthe bottom third of these stocks
"Beats" is the share of those stocks it is ahead of.
Against its own history
The last columns set today's figure against the company's own median of its last five financial years:
▲ Betterbetter than its usual level
▼ Worseworse than its usual level
≈ In linewithin its usual range
For valuation factors Good means cheaper than most of the sector and Better means cheaper than usual for this company, which is not the same as a bargain.
In total: 5 Good · 9 Average · 7 Bad of 21
Growth: 1 · 1 · 0
Profitability: 1 · 2 · 2
Financial strength: 2 · 1 · 1
Valuation: 0 · 2 · 3
Cash flow: 1 · 2 · 0
Efficiency: 0 · 1 · 1
| Factor | EMR | Rating | Sector median | Own 5-year median | Against own history |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth, 3 years a year | +121.4% | Good beats 99% | +5.6% | – | – |
| Revenue growth, last year | +3.0% | Average beats 38% | +4.5% | +6.7% | ▼ Worse |
| Profitability | |||||
| Gross margin | 53.2% | Good beats 86% | 38.0% | 49.9% | ≈ In line |
| Operating margin | 17.6% | Average beats 55% | 17.5% | 17.0% | ≈ In line |
| Net margin | 13.8% | Average beats 59% | 12.8% | 18.1% | ▼ Worse |
| Return on invested capital | 8.2% | Bad beats 10% | 14.9% | – | – |
| Return on equity | 12.7% | Bad beats 24% | 23.7% | 21.2% | ▼ Worse |
| Financial strength | |||||
| Net debt / EBITDA | 2.3x | Average beats 34% | 1.8x | 1.9x | ▼ Worse |
| Interest cover | 50.0x | Good beats 76% | 21.4x | – | – |
| Current ratio | 0.90 | Bad beats 17% | 1.25 | 1.10 | ▼ Worse |
| Piotroski F-score | 7 / 9 | Good beats 68% | 6 / 9 | – | – |
| Valuation | |||||
| P/E ratio | 34.9x | Bad beats 23% | 28.9x | 22.7x | ▼ Worse |
| Price / book | 4.4x | Average beats 66% | 6.2x | 3.3x | ▼ Worse |
| Price / sales | 4.8x | Bad beats 29% | 3.5x | 3.6x | ▼ Worse |
| EV / EBITDA | 21.2x | Bad beats 31% | 18.5x | 17.0x | ▼ Worse |
| Free cash flow yield | 3.8% | Average beats 51% | 3.8% | 4.1% | ≈ In line |
| Cash flow | |||||
| Free cash flow margin | 18.6% | Good beats 76% | 13.8% | 15.7% | ▲ Better |
| Cash from operations / net income | 1.52 | Average beats 61% | 1.39 | 1.13 | ▲ Better |
| Accruals (lower is better) | −3.2% | Average beats 48% | −3.2% | – | – |
| Efficiency | |||||
| Inventory turnover | 3.5x | Bad beats 30% | 4.0x | 3.9x | ≈ In line |
| Days sales outstanding | 60 days | Average beats 44% | 57 days | 61 days | ≈ In line |
These ratings compare companies with each other and describe the past; they are not a forecast, a recommendation or part of the X-Ray Score. A factor is left out when its data is missing or meaningless (for example a P/E on negative earnings). A dash in the history columns means fewer than three usable years.
Fundamentals checklist
● 5 Good · ● 6 Average · ● 3 BadCash quality
Earnings backed by cashAverage
Free-cash-flow yieldAverage
Risk models
Altman Z''Good
Piotroski F-ScoreGood
Growth
Revenue growth (3y)Good
Growth consistencyGood
Balance sheet
Current ratioBad
Net debt / EBITDAAverage
Interest coverGood
Valuation
Fair value vs priceAverage
EBIT / EV yieldBad
Profitability
Return on invested capitalBad
Operating marginAverage
Gross profitabilityAverage
Each check is graded against the company's sector, not a fixed number. Checklist score 53/100.
Financials
| FY22 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $13.8B | $1.7B | $15.2B | $17.5B | $18.0B |
| Operating income | $2.4B | – | $2.9B | $2.0B | $2.9B |
| Net income | $3.2B | – | $13.2B | $2.0B | $2.3B |
| Operating cash flow | $2.9B | – | $637M | $3.3B | $3.1B |
| Operating margin | 17.6% | – | 19.1% | 11.5% | 16.3% |
| Free cash flow | $2.6B | – | $274M | $2.9B | $2.7B |
| Diluted EPS | $5.41 | – | $22.88 | $3.43 | $4.04 |
Fiscal years, from SEC filings.
Technical summary
Daily
Bullish
8 bullish · 4 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
| SMA 10 | 161.7 | Bearish |
| EMA 10 | 161.1 | Bearish |
| SMA 20 | 160.5 | Bearish |
| EMA 20 | 159.8 | Bullish |
| SMA 50 | 156.4 | Bullish |
| EMA 50 | 156.3 | Bullish |
| SMA 100 | 150.6 | Bullish |
| EMA 100 | 151.9 | Bullish |
| SMA 200 | 145.7 | Bullish |
| EMA 200 | 146.1 | Bullish |
Oscillators (daily)
| RSI (14) | 53.24 | Neutral |
| MACD (12, 26) | 1.87 | Bullish |
| Momentum (12) | -0.69 | Bearish |
| Stochastic %K (14) | 53.82 | Neutral |
| Williams %R (14) | -46.18 | Neutral |
| CCI (20) | -47.82 | Neutral |
Pivot points (classic, last session)
S3 148.3 | S2 151.4 | S1 155.9 | Pivot 158.9 | R1 163.4 | R2 166.5 | R3 170.9 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.22 USD
Yield on today's price
1.38%
Frequency
Quarterly
Next ex-dividend date
Not announced
| Ex-dividend date | Amount per share |
|---|---|
| 0.5550 | |
| 0.5550 | |
| 0.5550 | |
| 0.5550 | |
| 0.5275 | |
| 0.5275 | |
| 0.5275 | |
| 0.5275 | |
| 0.5250 | |
| 0.5250 | |
| 0.5250 | |
| 0.5250 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
ETFs that hold EMR
| ETF | Share of the fund |
|---|---|
| PAVE Global X U.S. Infrastructure Developme... | 2.64% |
| KNG FT Cboe Vest S&P 500 Dividend Aristocr... | 1.47% |
| NOBL ProShares S&P 500 Dividend Aristocrats | 1.46% |
| XLI Industrial Select Sector SPDR | 1.39% |
| RSPN Invesco S&P 500 Equal Weight Industria... | 1.29% |
| FIDU Fidelity MSCI Industrials Index | 1.20% |
| JEPI JPMorgan Equity Premium Income | 1.18% |
| VIS Vanguard Industrials | 1.15% |
The eight funds with the largest weight in EMR among the ETFs we cover, from each fund's latest SEC Form N-PORT (quarter-end positions, so they can be months old). All ETFs.
EMR stock splits
EMR has split its stock 2 times since 1997. The latest was a 2-for-1 split on 12 Dec 2006.
Full EMR stock split history →EMR SEC filings
8-KSEC EDGAR
Results of operations
10-QSEC EDGAR
Quarterly report
8-KSEC EDGAR
Results of operations
10-QSEC EDGAR
Quarterly report
8-KSEC EDGAR
Results of operations; Director or officer change
8-KSEC EDGAR
Entered a material agreement
8-KSEC EDGAR
Shareholder vote results
10-QSEC EDGAR
Quarterly report
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.